TrialInternational journal of hematology2015

A randomized controlled trial comparing darbepoetin alfa doses in red blood cell transfusion-dependent patients with low- or intermediate-1 risk myelodysplastic syndromes.

Jun Ho Jang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.